KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Operating Expenses (2016 - 2025)

Historic Operating Expenses for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $119.8 million.

  • West Pharmaceutical Services' Operating Expenses rose 2101.01% to $119.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $442.9 million, marking a year-over-year increase of 744.78%. This contributed to the annual value of $407.6 million for FY2024, which is 336.65% down from last year.
  • West Pharmaceutical Services' Operating Expenses amounted to $119.8 million in Q3 2025, which was up 2101.01% from $115.0 million recorded in Q2 2025.
  • Over the past 5 years, West Pharmaceutical Services' Operating Expenses peaked at $119.8 million during Q3 2025, and registered a low of $79.9 million during Q3 2022.
  • Moreover, its 5-year median value for Operating Expenses was $104.3 million (2024), whereas its average is $103.1 million.
  • Per our database at Business Quant, West Pharmaceutical Services' Operating Expenses crashed by 2390.48% in 2022 and then skyrocketed by 3191.49% in 2023.
  • Over the past 5 years, West Pharmaceutical Services' Operating Expenses (Quarter) stood at $111.7 million in 2021, then decreased by 9.04% to $101.6 million in 2022, then increased by 6.69% to $108.4 million in 2023, then decreased by 4.24% to $103.8 million in 2024, then increased by 15.41% to $119.8 million in 2025.
  • Its Operating Expenses was $119.8 million in Q3 2025, compared to $115.0 million in Q2 2025 and $104.3 million in Q1 2025.